Periodic Reporting for period 1 - BoneScreen (An ex vivo platform to screen drug effects on bone)

Drug development remains a long and costly process with low success rates in clinical trials. This is even more pronounced in bone diseases that can have various underlying causes and often develop slowly before they can even be diagnosed. On top of that, many cell-based drug...